Event group

Cancer 2026

Rollup page for related agenda records under Cancer 2026.

Direct answer: 25 related records and 218 agenda items are grouped here.

Related records25

All slices for this event.

Usable records2

Usable agenda slices.

Strong records2

Gold/silver strong records.

Agenda items218

Combined extracted items.

Best score33

Best related record.

Related Records

Related records may include overview, day schedule, track, and session-detail pages.

This academic research science agenda in Academic / Research / Science shows 29 visible agenda rows from cancer.miconferences.com and scores 33/100: a thin but inspectable design signal. The clearest public signals sit in Future-of-Work Fit and Personalization; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 3329 Agenda ItemsPublication Polished

Source: cancer.miconferences.com

This broadcast-heavy conference in Academic / Research / Science shows 40 visible agenda rows from cancer.miconferences.com and scores 31/100: a thin but inspectable design signal. The clearest public signals sit in Personalization and Problem Specificity; the main limits are Follow Through and...

Academic / Research / ScienceBroadcast-heavy ConferenceGES 3140 Agenda ItemsPublication Polished

Source: cancer.miconferences.com

Scientific Topics - Types of Cancer - Cancer Research and Clinical Trials27

This lead or directory source in Academic / Research / Science shows 8 visible agenda rows from cancer.miconferences.com and scores 27/100: a weak visible outcome architecture. The clearest public signals sit in Participation Architecture and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 278 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Prevention and Epidemiology - Future Directions in Cancer Research21

This academic research science agenda in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 21/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Participation Architecture; the main limits are Follow...

Academic / Research / ScienceAcademic Research Science AgendaGES 217 Agenda Items

Source: cancer.miconferences.com

Scientific Topics - Prevention and Epidemiology20

This lead or directory source in Academic / Research / Science shows 8 visible agenda rows from cancer.miconferences.com and scores 20/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 208 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational resea20

This applied learning or working session in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 20/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Participation Architecture; the main limits are...

Academic / Research / ScienceApplied Learning or Working SessionGES 204 Agenda Items

Source: cancer.miconferences.com

Scientific Topics - Cancer Drugs, Vaccines, and Drug Development19

This lead or directory source in Academic / Research / Science shows 8 visible agenda rows from cancer.miconferences.com and scores 19/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 198 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Types of Cancer19

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 19/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 197 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Cancer Genetics and Genomics19

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 19/100: a weak visible outcome architecture. The clearest public signals sit in Personalization and Problem Specificity; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 197 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Cancer Detection and Diagnosis - Next-Generation Technologies in Oncology: AI, Big Data, Digital He19

This technology ai startup agenda in Technology / AI / Startup shows 7 visible agenda rows from cancer.miconferences.com and scores 19/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Technology / AI / StartupTechnology AI Startup AgendaGES 197 Agenda Items

Source: cancer.miconferences.com

Scientific Topics - Cancer Treatments - Survivorship and Long-Term Care19

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 19/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 197 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Cancer Detection and Diagnosis18

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 18/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Learning Transfer; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 187 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Case Reports18

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 18/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 187 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Palliative Care and Supportive Oncology18

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 18/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Learning Transfer; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 187 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Program Scientific Program 2026 Comparison of Single Port Robotic Breast Conserving Surgery and Conventional Open Pattern for Early Breast Cancer18

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 18/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Evidence Maturity; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 184 Agenda Items

Source: cancer.miconferences.com

Scientific Topics - Cancer Treatments17

This lead or directory source in Academic / Research / Science shows 8 visible agenda rows from cancer.miconferences.com and scores 17/100: a weak visible outcome architecture. The clearest public signals sit in Personalization and Problem Specificity; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 178 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics16

This lead or directory source in Academic / Research / Science shows 15 visible agenda rows from cancer.miconferences.com and scores 16/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Evidence Maturity; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 1615 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Scientific Topics - Types of Cancer - Cancer Biology16

This lead or directory source in Academic / Research / Science shows 7 visible agenda rows from cancer.miconferences.com and scores 16/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Future-of-Work Fit; the main limits are Follow Through and...

Academic / Research / ScienceLead or Directory SourceGES 167 Agenda ItemsLead/source Warning

Source: cancer.miconferences.com

Precise deep detection of tumoral biomarkers using large-scale confocal x-ray fluorescence16

This academic research science agenda in Academic / Research / Science shows 6 visible agenda rows from cancer.miconferences.com and scores 16/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Learning Transfer; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 166 Agenda Items

Source: cancer.miconferences.com

Patient report16

This academic research science agenda in Academic / Research / Science shows 5 visible agenda rows from cancer.miconferences.com and scores 16/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 165 Agenda Items

Source: cancer.miconferences.com

Precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing per15

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 15/100: a weak visible outcome architecture. The clearest public signals sit in Personalization and Problem Specificity; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 154 Agenda Items

Source: cancer.miconferences.com

Anti-cancer nanomedicine in humans: A review and future directions14

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 14/100: a weak visible outcome architecture. The clearest public signals sit in Personalization and Problem Specificity; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 144 Agenda Items

Source: cancer.miconferences.com

Iodine and Caesium-137: Angels and Demons of evolutionary Biology, in Pancreatic Cancer and Diabetes14

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 14/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Personalization; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 144 Agenda Items

Source: cancer.miconferences.com

Precision Oncology in Gynecologic Cancers: Molecular Taxonomy, Biomarker-Guided Therapeutics, and th13

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 13/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Evidence Maturity; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 134 Agenda Items

Source: cancer.miconferences.com

Program Scientific Program 2026 Polyphyllin D Inhibits Chaperone Mediated Autophagy By Targeting the Hsc70 Lamp2a Interaction in Non Small Cell Lun12

This academic research science agenda in Academic / Research / Science shows 4 visible agenda rows from cancer.miconferences.com and scores 12/100: a weak visible outcome architecture. The clearest public signals sit in Problem Specificity and Evidence Maturity; the main limits are Follow Through...

Academic / Research / ScienceAcademic Research Science AgendaGES 124 Agenda Items

Source: cancer.miconferences.com

How To Read The Corpus

The site is built for readers first: plain terms, source links, visible limitations, and role-specific next steps.

Agenda records

Source pages or agenda slices captured from public event sites. One large event may produce several records.

Event groups

Deduplicated clusters that gather related agenda, day, track, session, and source pages for one event.

GES

The Gathering Effectiveness Score: a strict 0-100 public-evidence reading of visible outcome architecture, not an award or causal proof claim.

Primary source

The source URL is the evidence trail. Open it before using a record for decisions, sponsorship, research, or comparison.

Choose Your Path

The same corpus answers different questions depending on whether you own, fund, design, sponsor, or package events.

Event ownersStart

Benchmark the agenda before the budget is locked.

Inspect whether the agenda creates qualified movement, not just visibility.

Event designersDesign

Turn passive blocks into participant work and proof loops.

Require outcomes, owners, and follow-through before another big room.

Data partnersData

Turn public event listings into agenda intelligence.

Answer Engine Notes

What is an event group rollup?

It groups related agenda slices that appear to belong to the same event.

Why are there multiple records?

Public event sites often expose overview, day, track, session, and schedule pages separately.